(Q28728799)
Statements
Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes (English)
0 references
16 June 2010
0 references
1
0 references
6
0 references
420-34
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference